PharmacoEconomics and Outcomes News

Cost effectiveness of cardiovascular therapies hugely variable
pp. 1-1(1)

Little evidence for benefits with direct-to-consumer advertising
pp. 2-2(1)

State compulsion should be "last resort" for HPV vaccination
pp. 2-2(1)

Insulin glargine adds up to value for diabetes in the UK
pp. 3-4(2)

WHO guidelines for kids with pneumonia ± HIV-1 inadequate
pp. 5-5(1)

Off-label or untested use of drug-eluting stents warranted?
pp. 5-5(1)

Authorised generic pharmaceuticals reduce the price and increase the availability of generic medicines
pp. 5-5(1)

Graded activity no more effective, no less costly in OA
pp. 6-6(1)

Unintended pregnancy cost high in the US
pp. 6-6(1)

Telbivudine good value for patients with chronic hepatitis B
pp. 6-6(1)

Cell salvage good value for blood transfusion
pp. 6-6(1)

Improved hospital management of ACS improves outcomes
pp. 7-7(1)

One for all, and all for one
pp. 7-7(1)

Many patients who are receiving twice-daily lansoprazole for gastro-oesophageal reflux disease (GERD) can be switched to once-daily rabeprazole
pp. 7-7(1)

β-blockers continue to be prescribed as first-line therapy in elderly patients
pp. 7-7(1)

Adherence-improving strategy cost effective for hypertension?
pp. 8-8(1)

A cautionary tale
pp. 8-8(1)

A dollar in, more than a dollar back
pp. 9-9(1)

Antipsychotics comparable for improving QOL in schizophrenia
pp. 9-9(1)

β-blockers: no QOL impairment
pp. 9-9(1)

Dextranomer/hyaluronan injection improves QOL in kids with VUR
pp. 9-9(1)

WHO recommendations to establish a stockpile of vaccine against H5N1 influenza virus have received support from vaccine manufacturers
pp. 10-10(1)

The UK Labour government is welcoming reports from NHS clinical directors as an indication of improvements
pp. 10-10(1)

Brazil breaks efavirenz patent, hailed as victory by AHF
pp. 10-10(1)

Growing use of biologicals for immunologic disease in the US
pp. 10-10(1)

The introduction of a generic version of sanofi-aventis' Ambien [zolpidem] will enable "multi-million dollar savings"
pp. 10-10(1)

Access to healthcare and certain key health indicators have improved in Afghanistan
pp. 11-11(1)

Drugs cheaper than average in new EU member states
pp. 11-11(1)

Bayer HealthCare is supporting the WHO in its attempt to eradicate Chagas' disease from Latin America.
pp. 11-11(1)